Viking Therapeutics, Inc. · NASDAQ:VKTX
BlackRock, Inc.'s stake in Viking Therapeutics, Inc. fell to 4.50% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 23, 2025
BlackRock, Inc.'s stake in Viking Therapeutics, Inc. fell to 4.50%, 5,031,511 shares, as a passive investor on Mar 31, 2025. Filed Apr 23, 2025 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 5,031,511
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.50% | 5,031,511 |
Source
Related
- Viking Therapeutics, Inc.
- BlackRock, Inc.
- Viking Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Form 4 · Kelly-Gemmell Dorothy Elizabeth · Aug 7, 2026
- Form 4 · Lian Brian · Jul 29, 2026
- Form 4 · Zante Greg · Jul 29, 2026
- Form 4 · Mancini Marianna · Jul 29, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026